trending Market Intelligence /marketintelligence/en/news-insights/trending/paisbftn3rhpmd2h6rqo6a2 content esgSubNav
In This List

Atara Biotherapeutics appoints CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Atara Biotherapeutics appoints CFO

Atara Biotherapeutics Inc. named Utpal Koppikar to the position of CFO.

Koppikar most recently served at Gilead Sciences Inc. as vice president for corporate and operations finance.

South San Francisco, Calif.-based Atara Biotherapeutics develops allogeneic T-cell immunotherapy to treat cancer, autoimmune and viral diseases.